These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 4581828)

  • 1. [The effect of infection in urinary calculosis. Lithogenic activity in vivo of a strain of Proteus mirabilis].
    Fontana G; Savoia D
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1972; 65(5):190-3. PubMed ID: 4581828
    [No Abstract]   [Full Text] [Related]  

  • 2. [Importance of infection in urinary calculosis. Lithogenic effect in vitro of a Proteus mirabilis strain].
    Fontana G; Savoia D; Martinetto P
    G Batteriol Virol Immunol Ann Osp Maria Vittor Torino; 1971; 64(9):352-61. PubMed ID: 4949683
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple renal abscesses due to Proteus mirabilis.
    Kakuchi Y
    Clin Exp Nephrol; 2021 Mar; 25(3):322-323. PubMed ID: 33070221
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccines for Proteus mirabilis in urinary tract infection.
    Li X; Mobley HL
    Int J Antimicrob Agents; 2002 Jun; 19(6):461-5. PubMed ID: 12135833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid-mediated multiple antibiotic resistance in Proteus mirabilis isolated from patients with urinary tract infection.
    Khan AU; Musharraf A
    Med Sci Monit; 2004 Nov; 10(11):CR598-602. PubMed ID: 15507850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of hospital strains of Proteus mirabilis by the methods of proticine and bacteriophage typing].
    Zawieja M
    Med Dosw Mikrobiol; 1988; 40(4):213-8. PubMed ID: 3073282
    [No Abstract]   [Full Text] [Related]  

  • 7. Defined mutants of Proteus mirabilis lacking flagella cause ascending urinary tract infection in mice.
    Legnani-Fajardo C; Zunino P; Piccini C; Allen A; Maskell D
    Microb Pathog; 1996 Nov; 21(5):395-405. PubMed ID: 8938645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flagellate and non-flagellate Proteus mirabilis in the development of experimental urinary tract infection.
    Zunino P; Piccini C; Legnani-Fajardo C
    Microb Pathog; 1994 May; 16(5):379-85. PubMed ID: 7815921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteus mirabilis spondylodiscitis complicating a urinary tract infection.
    Smits JP; Peltenburg HG; Mooi-Kokenberg EA; Koster T
    Scand J Infect Dis; 2006; 38(6-7):575-6. PubMed ID: 16798719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and serological properties of the O-antigen of two clinical Proteus mirabilis strains classified into a new Proteus O77 serogroup.
    Drzewiecka D; Arbatsky NP; Shashkov AS; Staczek P; Knirel YA; Sidorczyk Z
    FEMS Immunol Med Microbiol; 2008 Nov; 54(2):185-94. PubMed ID: 18665848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Enteropathogenicity of Proteus mirabilis bacteria and pathogenesis of experimental intestinal infections caused by them].
    Bidnenko SI; Bernasovskaia EP; Anisimova IuN; Barshteĭn IuA; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(6):81-8. PubMed ID: 3917194
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of a novel injectable cephalosporin, Cefclidin, on the experimental complicated urinary tract infections with urinary stones caused by Pseudomonas aeruginosa and Proteus mirabilis.
    Satoh M; Munakata K; Takeuchi H; Yoshida O
    Hinyokika Kiyo; 1994 Aug; 40(8):689-94. PubMed ID: 7942366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A boy with abdominal pain and when urinating. Urinary stones in a mega urethra].
    Hack WW; van der Horst HJ
    Ned Tijdschr Geneeskd; 2009 Feb; 153(6):244. PubMed ID: 19271445
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical epidemiology of ciprofloxacin-resistant Proteus mirabilis isolated from urine samples of hospitalised patients.
    Saito R; Okugawa S; Kumita W; Sato K; Chida T; Okamura N; Moriya K; Koike K
    Clin Microbiol Infect; 2007 Dec; 13(12):1204-6. PubMed ID: 17850340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Epidemiological application of the Cradock-Watson system for Proteus mirabilis. Comparative study with another system of bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández-Crehuet M; Rubio Peiró R; Piédrola Angulo G
    Rev Latinoam Microbiol; 1985; 27(2):77-81. PubMed ID: 3906814
    [No Abstract]   [Full Text] [Related]  

  • 16. [Detection of bacteriocin production by Proteus mirabilis. Proposal for a new protocol for bacteriocin typing].
    Rubio Peiró A; Liébana Ureña J; Castillo Pérez A; Fernández Crehuet M; Cueto Espinar A; Piédrola Angulo G
    Rev Latinoam Microbiol; 1984; 26(4):299-303. PubMed ID: 6395246
    [No Abstract]   [Full Text] [Related]  

  • 17. [Microbiological and pathomorphologic characteristics of experimental intestinal Proteus infections].
    Barshteĭn IuA; Bidnenko SI; Anisimova IuN; Koval'chuk VK; Mel'nitskaia EV
    Mikrobiol Zh (1978); 1985; 47(5):90-6. PubMed ID: 3917193
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug resistance and proticinogenic types of Proteus mirabilis isolated from urinary tract infections].
    Szymaniak L; Aleksandrowicz I; Giedrys-Kalemba S
    Med Dosw Mikrobiol; 1999; 51(3-4):323-30. PubMed ID: 10803261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulcer infection by ESbetaL-producing Proteus mirabilis: a case report.
    Savini V; Catavitello C; Talia M; Di Berardino F; Manna A; Balbinot A; Febbo F; Carlino D; Fioritoni F; Di Bonaventura G; D'Antonio D
    Int J Low Extrem Wounds; 2008 Jun; 7(2):99-101. PubMed ID: 18483010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differentiation of Proteus mirabilis and Proteus vulgaris strains by means of proticine typing: a longitudinal epidemiological study.
    Sekaninová G; Kolárová M
    Cent Eur J Public Health; 1996 May; 4(2):98-101. PubMed ID: 8996720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.